4720-83-6

Basic information

• Product Name: 6-OXABICYCLO[3.2.1]OCT-3-EN-7-ONE
• Synonyms: 6-OXABICYCLO[3.2.1]OCT-3-EN-7-ONE
• CAS NO: 4720-83-6
• Molecular Formula: C₇H₈O₂
• Molecular Weight: 124.13722
• Mol File: 4720-83-6.mol
• Article Data: 22

Chemical Properties

• Boiling Point: 263.1°C at 760 mmHg
• Flash Point: 104°C
• Appearance: /
• Density: 1.196g/cm³
• Vapor Pressure: 0.0105mmHg at 25°C
• Refractive Index: 1.522
• CAS DataBase Reference: 6-OXABICYCLO[3.2.1]OCT-3-EN-7-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-OXABICYCLO[3.2.1]OCT-3-EN-7-ONE(4720-83-6)
• EPA Substance Registry System: 6-OXABICYCLO[3.2.1]OCT-3-EN-7-ONE(4720-83-6)

Safety Data

• Hazardous Substances Data: 4720-83-6(Hazardous Substances Data)

Usage

Uses

6-Oxabicyclo[3.2.1]oct-3-en-7-one is used in the convergent total synthesis of Leustroducsin B.

InChI:InChI=1/C7H8O2/c8-7-5-2-1-3-6(4-5)9-7/h1,3,5-6H,2,4H2

Upstream product

• 4771-80-6 1,2,5,6-tetrahydrobenzoic acid 
• 19914-92-2 (+/-)-4-iodo-6-oxabicyclo[3.2.1]octan-7-one 
• 76140-13-1 endo-4-iodo-6-oxabicyclo<3,2,1>octan-7-one 
• 72359-56-9 3-acetoxy-5-carbomethoxy-1-cyclohexene 
• 54911-89-6 cis-methyl 5-hydroxycyclohex-3-enecarboxylate 
• 71404-67-6 4-(phenylseleno)-6-oxabicyclo<3.2.1>octan-7-one 
• 79433-96-8 methyl 5-hydroxy-3-cyclohexenecarboxylate 

Downstream Products

• 79433-96-8 methyl 5-hydroxy-3-cyclohexenecarboxylate 
• 54911-89-6 cis-methyl 5-hydroxycyclohex-3-enecarboxylate 
• 84011-69-8 5-<<<(1,1-dimethylethyl)dimethylsilyl>oxy>methyl>-2-cyclohexen-1-one 
• 123453-95-2 (1S,5S)-(-)-5-(hydroxymethyl)-2-cyclohexen-1-ol 

Relevant articles and documents

Catalytic Aza-Wacker Annulation: Tuning Mechanism by the Activation Mode of Amide and Enantioselective Syntheses of Melinonine-E and Strychnoxanthine

An unprecedented N-substituent of the amide was found to be crucial for the successful annulation to establish 2-azabicyclo[3.3.1]nonane and other ring skeletons in good yield. The novel catalytic aza-Wacker annulation methodology was further illustrated

NOVEL COMPOUNDS

Novel rapamycin analogues and methods for their production with FKBP and/or MIP inhibitory activity with reduced mTOR inhibitory activity with therapeutic potential e.g. as bacterial virulence inhibitors.